Literature DB >> 9178698

Bacterial lipase and high-fat diets in canine exocrine pancreatic insufficiency: a new therapy of steatorrhea?

A Suzuki1, A Mizumoto, M G Sarr, E P DiMagno.   

Abstract

BACKGROUND & AIMS: Nutrients and properties of lipases affect survival of lipolytic activity during aboral gastrointestinal transit. Whether different doses and formulations of bacterial lipase and diets affect steatorrhea was tested in pancreatic-insufficient dogs.
METHODS: A dose of 0-600,000 IU of powdered and 135,000 and 300,000 IU of liquid bacterial lipase was given with a standard meal to 5 dogs with ligated pancreatic ducts. In 4 dogs, 0 or 300,000 IU (normal 6-hour postprandial amount) of powder bacterial lipase was also given with five meals containing 850 kcal with different nutrient caloric densities (mixture design). Coefficients of fat absorption during 72-hour fecal balance studies were used to assess treatments.
RESULTS: With the standard meal, powder bacterial lipase reduced steatorrhea in a dose-dependent manner (P = 0.03), and 135,000 and 300,000 IU of the liquid form decreased steatorrhea more than powder bacterial lipase (P = 0.017 and 0.057, respectively). Coefficients of fat absorption with 300,000 IU of powder bacterial lipase correlated (r2 = 0.79; P < 0.001) with increasing proportions of fat calories in diets.
CONCLUSIONS: Liquid bacterial lipase decreases steatorrhea more than powder, and 300,000 IU of powder bacterial lipase ingested with high-fat meals corrects canine pancreatic steatorrhea. The combination of adequate mixing of small amounts (milligrams) of bacterial lipase and high-fat meals abolishes canine steatorrhea and may abolish human pancreatic steatorrhea.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178698     DOI: 10.1053/gast.1997.v112.pm9178698

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Pancreatic enzyme replacement therapy.

Authors:  P Layer; J Keller; P G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 2.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

3.  Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency.

Authors:  Sophie Drouault; Catherine Juste; Philippe Marteau; Pierre Renault; Gérard Corthier
Journal:  Appl Environ Microbiol       Date:  2002-06       Impact factor: 4.792

Review 4.  Pancreatic enzyme therapy.

Authors:  Joachim Mössner; Volker Keim
Journal:  Dtsch Arztebl Int       Date:  2010-08-29       Impact factor: 5.594

Review 5.  Treatment of pancreatic exocrine deficiency.

Authors:  Martin Sarner
Journal:  World J Surg       Date:  2003-10-13       Impact factor: 3.352

6.  Pancreatic Enzyme Supplementation Therapy.

Authors:  Jutta Keller; Peter Layer
Journal:  Curr Treat Options Gastroenterol       Date:  2003-10

7.  Effect of enzyme supplements on macronutrient digestibility by healthy adult dogs.

Authors:  Cecilia Villaverde; Edgar G Manzanilla; Jenifer Molina; Jennifer A Larsen
Journal:  J Nutr Sci       Date:  2017-04-18

8.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.